The dual effects of GLP-1RAs, such as modulatory actions to immune cells (lymphocytes, microglia, astrocytes, etc ) and trophic and protective activities to oligodendrocytes and Schwann cells, would be variable for the strategies of myelin protection and repair in the CNS and PNS
V2 the volume of perchloric acid standard solution consumed in titrating the blank solution, in milliliters (mL)
The GLP-1 RAs appear to modify atherosclerosis in the arteries, much like statin medications that treat cholesterol, and takes about a year or more to demonstrate measurable benefits on risk for cardiovascular events, whereas the SGLT2i medications seem to affect heart and kidney function more prominently and faster, with benefits evident very soon after starting the medication
Ongoing clinical trials are working to further evaluate its long-term efficacy, safety, and optimal dosing strategies
If you miss a dose, take it as soon as possible within 5 days
What the research supports